Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vishal Devarkonda
Simultaneous Targeting of 5-Lox-Cox and EGFR Blocks Progression of Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
Related publications
EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival
Oncology Letters
Cancer Research
Oncology
Fibroblast Activation Protein Augments Progression and Metastasis of Pancreatic Ductal Adenocarcinoma
JCI insight
Medicine
Increased CDC20 Expression Is Associated With Pancreatic Ductal Adenocarcinoma Differentiation and Progression
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Molecular Targeting of Cell-Permeable Peptide Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation
Oncotarget
Oncology
Upregulation of miR-194 Contributes to Tumor Growth and Progression in Pancreatic Ductal Adenocarcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
UBL4A Inhibits Autophagy-Mediated Proliferation and Metastasis of Pancreatic Ductal Adenocarcinoma via Targeting LAMP1
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Features of Immunophenotype of Pancreatic Ductal Adenocarcinoma
Zaporozhye Medical Journal
A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma
Nucleic Acid Therapeutics
Biochemistry
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
Progression of Pancreatic Adenocarcinoma Is Significantly Impeded With a Combination of Vaccine and COX-2 Inhibition
Journal of Immunology
Allergy
Immunology